https://www.selleckchem.com/products/blu-667.html
CR was achieved in 85% of the chemoradiotherapy group, and the rate tended to increase with TPF efficacy. CR was achieved in 84% (26/31) of patients receiving BRT, 88% (7/8) receiving CDDP-RT, and 100% (1/1) receiving RT. The 2-year survival rates were 92% overall, and 97% and 79% in the chemoradiotherapy and surgery groups, respectively. When facing difficulty in deciding between chemoradiotherapy and surgery, one course of TPF may be an effective option. When facing difficulty in deciding between chemoradiotherapy and surgery, one cou
Like
Comment
Share
